Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

Ingevity CorporationNYSE: NGVT

Change in Working Capital · Q3 FY2026 · quarter ended Sep 2026

Change in working capital outflow shrinks to $0

Q3 FY2026 change in working capital was $0, compared with $24.7M a year earlier. Trailing-twelve-month change in working capital was -$39.2M.

Context

  • Change in working capital amounted to 1.9% of revenue in FY2025, up 1.2 pp from a year earlier.
  • Change in working capital increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly change in working capital holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$9.8M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$22.7M+327.0% YoY
LTMSep 2026
-$39.2M-561.2% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+327.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
22.7M USD
Year-over-year change
+327.0%
4-year CAGR
-7.1%

Change in Working Capital vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -561.2% is the lowest of 10, against a peer median of +154.4%.
  • Change in working capital amounts to 3.5% of revenue for NGVT, versus a peer median of 5.0%.
NGVT Competitors
Change in Working Capital for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMCFMC CorporationLTM Mar 2026$485.2M USD+5817.1%+18.9%14.1%
CCThe Chemours CompanyLTM Jun 2026$289M USD+91.4%—5.0%
AAUCAllied Gold CorporationLTM Jun 2026$212.06M USD+631.2%+120.8%14.2%
ASHAshland Inc.LTM Jun 2026$204M USD+4180.0%-11.0%11.1%
OLNOlin CorporationLTM Jun 2026$194.8M USD+1364.7%+10.2%2.9%
ELVRElevra Lithium LimitedFY2025A$82.78M AUD——39.9%
MTXMinerals Technologies Inc.LTM Apr 2026$67M USD-37.7%-10.9%3.1%
IOSPInnospec Inc.LTM Jun 2026$51.5M USD-3.9%-18.7%2.8%
NGVTIngevity CorporationLTM Sep 2026$39.2M USD-561.2%—3.5%
KWRQuaker Chemical CorporationLTM Sep 2026$20.29M USD+154.4%-28.2%1.0%
SKESkeena Resources LimitedLTM Sep 2026CA$3.71M CAD+113.1%——
Peer median (excluding NGVT) —+154.4%-10.9%5.0%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
Deferred Income Tax(4.6M)(5M)(44.7M)(121.4M)(4.7M)
Stock-Based Compensation12.3M16.1M10.6M11.9M18.3M
Change in Working Capital30.5M(66.5M)(67.8M)(10M)22.7M
Accounts Receivables(13.8M)(42.1M)42.7M38.2M12.2M
Inventory(55.8M)(63.7M)25.8M86.2M40.2M
Accounts Payables14.8M42.7M(14.6M)(63.4M)(2.6M)
Other Working Capital85.3M(3.4M)(121.7M)(71M)(27.1M)
Other Non-Cash Items27.1M48.4M189.6M570.1M355.6M
Operating Cash Flow293.3M313.4M205.1M128.6M331.2M
Capital Expenditures(103.8M)(142.5M)(109.8M)(77.6M)(57.7M)
Acquisitions (Net)0(344.5M)000
Purchases of Investments(35.3M)(77.4M)(2.4M)(300K)(16.4M)
Sales of Investments014.7M31.5M013M
Other Investing Activities500K(2.2M)3.4M(1.6M)3.6M
Investing Cash Flow(138.6M)(551.9M)(77.3M)(79.5M)(57.5M)
Debt Repayment(26M)199M(6.6M)(67.1M)(193.6M)
Common Stock Issued4.7M04.7M01.4M
Common Stock Repurchased(109.4M)(145.2M)(92.1M)(3.1M)(56.3M)
Dividends Paid00000
Other Financing Activities(2.4M)(5.7M)(5.9M)0(3.7M)
Financing Cash Flow(133.1M)48.1M(99.9M)(70.2M)(252.2M)
Effect of Forex Changes(1.7M)(6M)(300K)(4.2M)4.5M
Net Change in Cash19.9M(196.4M)27.6M(25.3M)26M
Free Cash Flow189.5M170.9M95.3M51M273.5M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.